Echocardiogram
An ultrasound of the heart's chambers, valves and function, performed at your clinic by our sonographer network.
Mobile cardiac diagnostics for patients, GPs and institutions across Victoria — for over 40 years.
Cardiolab was established over 40 years ago as one of Victoria's first mobile cardiac diagnostic services.
In partnership and affiliation with









Clinical Diagnostics
The full suite of non-invasive cardiac diagnostics, performed at your clinic by our sonographer network and reported by consultant cardiologists.
An ultrasound of the heart's chambers, valves and function, performed at your clinic by our sonographer network.
Cardiac ultrasound performed under physical or pharmacological stress to assess how the heart performs under load.
Continuous ECG recording over 24–48 hours to capture intermittent rhythm disturbances.
Ambulatory blood pressure monitoring over a full day/night cycle to assess true blood pressure patterns.
An exercise ECG to assess the heart's electrical response to physical exertion.
A resting electrocardiogram capturing the heart's electrical activity at a single point in time.
48hReports reach the referring GP within 48 hours.
Patients can book directly or via GP referral — both pathways are live.
Ultrasound Education
A structured sonography training program run inside a working diagnostic practice — scanning real patients under supervision from the start.
“The sonography program gave me real hands-on scanning experience from week one, not just theory.”
Interested in the program? Register your interest through the Sonography Training track in Careers.
Biomedical Research
Cardiolab provides trial-grade cardiac imaging for research partners including Peter MacCallum Cancer Centre, the Doherty Institute and Nucleus Network.
A randomised, placebo-controlled Phase 1 study of MYK-491 (later known as danicamtiv) in healthy adult volunteers, sponsored by MyoKardia, Inc. and run at Nucleus Network, Melbourne. Cardiolab provided the trial’s echocardiography — transthoracic echo screening and LVEF/LVFS measurement against the study’s eligibility and outcome criteria.
MyoKardia was subsequently acquired by Bristol Myers Squibb for US$13.1 billion in cash (announced October 2020).
View the trial record on clinicaltrials.gov→Doherty Clinical Trials · Phase 1/2
Echocardiography for cardiac monitoring of trial participants.
View on clinicaltrials.gov→Nucleus Network · Phase 1
Echocardiography for cardiac safety assessment.
View on clinicaltrials.gov→Nucleus Network · Phase 1
Provided echocardiography for cardiac safety assessment.
View on clinicaltrials.gov→Exploring a study or an institutional partnership? Write to us directly.
Careers
We're not running live listings yet — register your interest and we'll be in touch when a position opens in your track.
Join the 3-month training program and learn cardiac sonography inside a working practice.
Coordinate clinics, cardiologists and a mobile sonographer network.
Be the first point of contact for patients and referring practices.
Locations & Contact
Patient & Referrer Feedback
“The whole process was quick and reassuring — I had my scan done locally and my GP had the results within two days.”
“As a referring GP, I appreciate how fast and clear the reports come back. It's made a real difference for my patients.”
“I felt well looked after throughout my daughter's echocardiogram — the team explained everything clearly.”